If selected, the location would house one of five centers at the heart of King County’s plans to expand the mental health ...

UnitedHealth Group CEO Andrew Witty will step down from his role at the top of the company due to personal reasons, the ...

UnitedHealth Group stock has plummeted since my last Buy rating and is ~55% off highs, but its lower valuation now offers a ...

There’s new leadership at the nation’s largest healthcare company, but the transition brings a familiar face back to the helm after a tumultuous year for UnitedHealth Group. Ten notes: 1. UnitedHealth ...

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q1 CY2025 results exceeding the market’s revenue ...

For years, UnitedHealth Group was the envy of the healthcare industry—a vertically integrated behemoth that controlled the ...

Biocon Biologics has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab). The market access agreements from numerous plans represent more ...

Capitol Hill property owners, businesses, and residents are preparing to push back on a planned King County mental health ...

The drug has been chosen as the sole ustekinumab by BCBSM, Florida Healthcare Plan, and other closed-door health systems.

CEO Andrew Witty this week has sent shockwaves through an already tumultuous healthcare sector. Investors in UNH stock have certainly had plenty of headwinds to deal with over the course of the past ...

Increased utilization in physician and outpatient services within Medicare Advantage was not mirrored in commercial or ...